ARENTFOX SCHIFF LLP for CSL BEHRING
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation pertaining to orphan drugs Orphan drug tax exclusion in the Patient Protection and Affordable Care Act
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. health care policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| NORMAN FREDERICK LENT | — |
| SONJA NESBIT | — |
Trade (domestic/foreign) TRD
Renewal of the Office of Foreign Assets Control license for toll manufacturing of therapies for international distribution
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. trade policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
Taxation/Internal Revenue Code TAX
Follow up tax legislation to tax reform
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. tax policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| SONJA NESBIT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.